Table 1.
Baseline characteristics of study population
| Controls (n = 195) | Cases (n = 85) | |
|---|---|---|
| Male (%) | 73.3 (66.5;79.4) | 72.9 (62.2;82.0) |
| Age (years) | 50.7 (6.3) | 51.2 (5.8) |
| BMI (kg/m2) | 26.0 (3.5) | 26.7 (3.8) |
| Height (cm) | 172.9 (9.1) | 172.2 (8.6) |
| Diastolic blood pressure (mmHg) | 79.5 (9.3) | 83.3 (9.9) |
| Systolic blood pressure (mmHg) | 119.4 (11.8) | 126.5 (14.8) |
| Total cholesterol (mmol/l) | 6.6 (1.2) | 6.6 (1.2) |
| HDL cholesterol (mmol/l) | 1.5 (0.4) | 1.3 (0.3) |
| LDL cholesterol (mmol/l) | 4.5 (1.1) | 4.5 (1.1) |
| Triglycerides (mmol/l) | 1.4 (0.9) | 1.7 (0.9) |
| CRP (mg/l) | 0.8 (0.5;1.7) | 1.0 (0.6;2.2) |
| Smoking habits | ||
| Never-smoker (%) | 50.3 (43.0;57.5) | 44.7 (33.9;55.9) |
| Ex-smoker (%) | 35.9 (29.2;43.1) | 41.2 (30.6;52.4) |
| Current smoker (%) | 13.8 (9.3;19.5) | 14.1 (7.5;23.4) |
| Fasting plasma glucose (mmol/l) | 5.1 (0.4) | 5.4 (0.5) |
| 2-hour plasma glucose (mmol/l) | 5.0 (1.1) | 6.6 (1.9) |
| Anti-hypertensive treatment (%) | 6.2 (3.2;10.5) | 12.9 (6.6;22.0) |
| Lipid-lowering treatment (%) | 0.5 (0.0;2.8) | 2.4 (0.3;8.2) |
Data are means (SD), medians (interquartile range) or proportions (95% CI)